Ribavirin downmodulates inducible costimulator on CD4+ T cells and their interleukin‐10 secretion to assist in hepatitis C virus clearance
- 22 August 2011
- journal article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 27 (4) , 823-831
Abstract
Background and Aim: The immunological mechanism by which ribavirin (RBV) polarizes the T‐helper (Th) 1/2 balance toward Th1 predominancy is not fully understood. We therefore examined whether RBV affects costimulatory signaling, which is known to be essential for regulating the Th1/2 balance.Methods: The expression of costimulatory molecules and their ligands, and levels of various cytokines, released from CD4+ T cells obtained from healthy individuals or patients with chronic hepatitis C virus (HCV) infection were analyzed.Results: In CD4+ T cells, RBV selectively downmodulates the expression of inducible costimulator (ICOS), a ligand for B7–H2 on dendritic cells, which mainly differentiates Th0 into Th2 cells. Moreover, the levels of interleukin‐10 (IL‐10) released from RBV‐stimulated CD4+ T cells also decreased, indicating that the downmodulation of ICOS induced by RBV might be correlated with the decrease in IL‐10 released from Th cells, leading to the inhibition of Th2 activity. An analysis of the association between ICOS kinetics and hepatitis C virus (HCV) elimination in hepatitis C patients receiving combined pegylated interferon and RBV indicated that HCV elimination tended to occur more frequently in patients showing ICOS downmodulation with RBV treatment. A decrease in IL‐10 production by CD4+ T cells was also observed in association with ICOS downregulation in patients who succeeded in HCV elimination.Conclusions: The downmodulation of ICOS in correlation with a reduction in IL‐10 produced by CD4+ T cells is possibly the immunological mechanism of action of RBV, which polarizes the Th1/2 balance toward a Th1 cytokine profile, thus contributing to the elimination of cells chronically infected with HCV.Keywords
This publication has 49 references indexed in Scilit:
- The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cellsNature Immunology, 2008
- Ribavirin in the treatment of chronic hepatitis CJournal of Gastroenterology and Hepatology, 2008
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- Mutagenic and Inhibitory Effects of Ribavirin on Hepatitis C Virus RNA PolymeraseBiochemistry, 2003
- Role of CD28 co-stimulation in generation and maintenance of virus-specific T cellsInternational Immunology, 2002
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.Journal of Experimental Medicine, 1995
- B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 1995
- CTLA-4 can function as a negative regulator of T cell activationImmunity, 1994
- Proliferating dendritic cell progenitors in human blood.Journal of Experimental Medicine, 1994